• Natera officer Solomon Moshkevich, president of clinical diagnostics, sold 3,000 common shares on June 1, 2026.
• Sales prices ranged from $217.52 to $220.67.
• He held 137,643 common shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natera Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002010019-26-000015), on June 03, 2026, and is solely responsible for the information contained therein.